These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31485040)

  • 1. Speed SPYing: adaptive clinical trials hit the gas.
    Zipkin M
    Nat Biotechnol; 2019 Sep; 37(9):975-977. PubMed ID: 31485040
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarker-led adaptive trial blazes a trail in breast cancer.
    Allison M
    Nat Biotechnol; 2010 May; 28(5):383-4. PubMed ID: 20458285
    [No Abstract]   [Full Text] [Related]  

  • 3. Neoadjuvant trials could speed up drug approvals.
    Peres J
    J Natl Cancer Inst; 2014 Mar; 106(3):dju072. PubMed ID: 24610911
    [No Abstract]   [Full Text] [Related]  

  • 4. Demystify statistical significance--time to move on from the p value to bayesian analysis.
    Lee JJ
    J Natl Cancer Inst; 2011 Jan; 103(1):2-3. PubMed ID: 21131578
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacodynamic endpoints in primary breast cancer.
    Di Cosimo S; Baselga J
    Ann Oncol; 2007 Jul; 18 Suppl 9():ix21-3. PubMed ID: 17631590
    [No Abstract]   [Full Text] [Related]  

  • 6. Bayesian monitoring of clinical trials with failure-time endpoints.
    Rosner GL
    Biometrics; 2005 Mar; 61(1):239-45. PubMed ID: 15737099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new math of clinical trials.
    Couzin J
    Science; 2004 Feb; 303(5659):784-6. PubMed ID: 14764863
    [No Abstract]   [Full Text] [Related]  

  • 8. Inflammatory breast cancer.
    Williams CJ
    J Clin Oncol; 1987 Jun; 5(6):986-7. PubMed ID: 3295134
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel insights in clinical trials with preoperative systemic therapy for primary breast cancer.
    Toi M; Bando H; Chow LW
    Biomed Pharmacother; 2004 Nov; 58(9):531-5. PubMed ID: 15599986
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer.
    Ratkin GA
    J Clin Oncol; 1987 Jan; 5(1):161-2. PubMed ID: 3543235
    [No Abstract]   [Full Text] [Related]  

  • 11. Trastuzumab for early breast cancer.
    Thorat M
    Lancet; 2006 Jan; 367(9505):108. PubMed ID: 16413867
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted Therapies in Older Adults With Breast Cancer: What Do We Know?
    Strulov Shachar S; Hurria A; Muss HB
    J Clin Oncol; 2016 Oct; 34(28):3486-8. PubMed ID: 27432932
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast tumours: a review of adjuvant chemotherapy trials.
    Plagne R
    Drugs Exp Clin Res; 1986; 12(1-3):135-42. PubMed ID: 3525067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive design of confirmatory trials: Advances and challenges.
    Lai TL; Lavori PW; Tsang KW
    Contemp Clin Trials; 2015 Nov; 45(Pt A):93-102. PubMed ID: 26079372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A remark on 'Bayesian predictive approach to interim monitoring in clinical trials' by A. Dmitrienko and M-D. Wang.
    Cai G; Zhou T
    Stat Med; 2012 Jul; 31(16):1774-6. PubMed ID: 22729893
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phases 0, 1 and 2 oncology clinical trials: current questions].
    Penel N; Fournier C; Stéphanie C
    Bull Cancer; 2010 Jan; 97(1):55-63. PubMed ID: 20080458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trend toward noninferiority trials may mean more difficult interpretation of trial results.
    Tuma RS
    J Natl Cancer Inst; 2007 Dec; 99(23):1746-8. PubMed ID: 18042926
    [No Abstract]   [Full Text] [Related]  

  • 18. Adaptive design in clinical research: issues, opportunities, and recommendations.
    Chang M; Chow SC; Pong A
    J Biopharm Stat; 2006 May; 16(3):299-309; discussion 311-2. PubMed ID: 16724486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic studies.
    Rubinstein LV
    Hematol Oncol Clin North Am; 2000 Aug; 14(4):849-76, ix. PubMed ID: 10949777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose chemotherapy in breast cancer--interpretation of the randomized trials.
    Rodenhuis S
    Anticancer Drugs; 2001 Feb; 12(2):85-8. PubMed ID: 11261891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.